Carvalho, André F. http://orcid.org/0000-0002-2500-5671
Solmi, Marco
Sanches, Marcos
Machado, Myrela O.
Stubbs, Brendon
Ajnakina, Olesya
Sherman, Chelsea
Sun, Yue Ran
Liu, Celina S.
Brunoni, Andre R. http://orcid.org/0000-0002-6310-3571
Pigato, Giorgio
Fernandes, Brisa S.
Bortolato, Beatrice
Husain, Muhammad I. http://orcid.org/0000-0001-5771-5750
Dragioti, Elena
Firth, Joseph
Cosco, Theodore D.
Maes, Michael
Berk, Michael
Lanctôt, Krista L.
Vieta, Eduard
Pizzagalli, Diego A. http://orcid.org/0000-0002-7772-1143
Smith, Lee
Fusar-Poli, Paolo http://orcid.org/0000-0003-3582-6788
Kurdyak, Paul A.
Fornaro, Michele
Rehm, Jürgen
Herrmann, Nathan
Article History
Received: 2 January 2020
Revised: 3 April 2020
Accepted: 1 May 2020
First Online: 18 May 2020
Competing interests
: A.F.C., Marco Solmi, M. Sanches, M.O.M., B.S., O.A., C.S., J.S., C.S.L., A.R.B., G.P., B.S.F., B.B., M.I.H., E.D., J.F., T.D.C., M.M., L.S., P.F.-P., P.A.K., M.F., J.R., and N.H. have no conflicts of interest to declare. M.B. has been a speaker for Astra Zeneca, Lundbeck, Merck, Pfizer, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Lundbeck Merck, Pfizer and Servier. K.L.L. has received consulting fees from AbbVie, Lundbeck/Otsuka, Pfizer, ICG Pharma, and Kondor in the last 3 years. E.V. has served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, Allergan, Angelini, AstraZeneca, Bristol-Myers Squibb, Dainippon Sumitomo Pharma, Farmindustria, Ferrer, Forest Research Institute, Gedeon Richter, Glaxo-Smith-Kline, Janssen, Lundbeck, Otsuka, Pfizer, Roche, SAGE, Sanofi-Aventis, Servier, Shire, Sunovion, Takeda. Over the past 3 years, D.A.P. has received consulting fees from Akili Interactive Labs, BlackThorn Therapeutics, Boehringer Ingelheim, Compass, Posit Science, and Takeda Pharmaceuticals and an honorarium from Alkermes for activities unrelated to the current work.